Revu Corporation (KOSDAQ:443250)
5,890.00
-180.00 (-2.97%)
At close: Jul 24, 2026
Revu Corporation Revenue
Revu Corporation had revenue of 13.27B KRW in the quarter ending March 31, 2026, with 11.06% growth. This brings the company's revenue in the last twelve months to 57.78B, up 15.16% year-over-year. In the year 2025, Revu Corporation had annual revenue of 56.46B with 18.05% growth.
Revenue (ttm)
57.78B
Revenue Growth
+15.16%
P/S Ratio
1.13
Revenue / Employee
n/a
Employees
n/a
Market Cap
65.27B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 56.46B | 8.63B | 18.05% |
| Dec 31, 2024 | 47.82B | 8.08B | 20.32% |
| Dec 31, 2023 | 39.75B | -521.35M | -1.29% |
| Dec 31, 2022 | 40.27B | 17.28B | 75.19% |
| Dec 31, 2021 | 22.99B | 5.68B | 32.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Korea Computer | 433.02B |
| SY Dong-A | 395.26B |
| ICD Co., Ltd. | 202.03B |
| Tplex | 93.85B |
| Innox | 58.16B |
| Joong Ang Enervis | 48.25B |
| JAS Robotics | 34.42B |
| PanGen Biotech | 13.71B |